Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,402,091,667
-
Total 13F shares
-
9,458
-
Share change
-
-12,354
-
Total reported value
-
$27,991
-
Price per share
-
$2.96
-
Number of holders
-
11
-
Value change
-
+$18,523
-
Number of buys
-
10
-
Number of sells
-
1
Institutional Holders of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) as of Q1 2025
As of 31 Mar 2025,
BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,458 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, RHUMBLINE ADVISERS, JPMORGAN CHASE & CO, Nemes Rush Group LLC, NewEdge Advisors, LLC, GROUP ONE TRADING LLC, UBS Group AG, and SBI Securities Co., Ltd..
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.